Lysine insertion during coded protein synthesis requires lysyl-tRNA Lys , which is synthesized by lysyl-tRNA synthetase (LysRS). Two unrelated forms of LysRS are known: LysRS2, which is found in eukaryotes, most bacteria and a few archaea, and LysRS1, which is found in most archaea and a few bacteria. To compare amino acid recognition between the two forms of LysRS, the effects of L-lysine analogues on aminoacylation were investigated. Both enzymes showed stereospecificity towards the L-enantiomer of lysine and discriminated against noncognate amino acids with different R-groups (arginine, ornithine). Lysine analogues containing substitutions at other positions were generally most effective as inhibitors of LysRS2. For example, the Kis for aminoacylation of S-(2-aminoethyl)-L-cysteine and L-lysinamide were over 180 fold lower with LysRS2 than with LysRS1. Of the other analogues tested, only γ-amino butyric acid showed a significantly higher Ki for LysRS2 than LysRS1. These data indicate that the lysine-binding site is more open in LysRS2 than in LysRS1, in agreement with previous structural studies. The physiological significance of divergent amino acid recognition was reflected by the in vivo resistance to growth inhibition imparted by LysRS1 against S-(2-aminoethyl)-L-cysteine and LysRS2 against γ-amino butyric acid. These differences in resistance to naturally occurring non-cognate amino acids suggest the distribution of LysRS1 and LysRS2 contributes to quality control during protein synthesis. In addition, the specific inhibition of LysRS1 indicates it is a potential drug target.
Introduction
The fidelity of coded protein synthesis is dependent on the accuracy of two processes; the matching of codons in mRNA with their corresponding anticodons in tRNA, and the aminoacylation of these tRNAs with amino acids defined by the anticodon. Aminoacyl-tRNA synthesis is a highly specific reaction catalyzed by the aminoacyl-tRNA synthetase (aaRS) protein family, each member of which is specific for a particular amino acid and tRNA (1;2).
Despite the remarkable precision aaRSs display in the recognition and selection of the correct amino acid and tRNA, proofreading and editing mechanisms are both required to maintain accuracy at a level consistent with faithful translation of the genetic code (3;4). Elongation factor Tu, which takes aminoacyl-tRNAs to the ribosomal decoding site, provides an additional level of quality control by screening for incorrectly aminoacylated tRNAs (5) .
The 20 aaRS proteins, as for example found in Escherichia coli (6) , are divided into two mutually exclusive structural groups of ten members each termed class I and class II (7;8) .
Structural studies have shown that in class I synthetases the active site contains a Rossmann dinucleotide binding domain, whereas this fold is absent from the active site of class II enzymes which instead contain a novel anti-parallel β-fold. One result of this difference in active site structure is that class I enzymes bind ATP in an extended conformation; class II in a bent 4 The assignment of an aaRS specific for a particular amino acid to one or the other structural class is almost completely conserved in all species, reflecting the antiquity of this dichotomy (10) . The only widespread exception observed to date is lysyl-tRNA synthetase (LysRS), which is found in both class I and class II (11) . Comparative genomic analysis has established that class I LysRSs are present in most archaea, a few bacteria, but no eukaryotes (12) . As a result of microbial genome sequencing, over 40 class I LysRSs have now been identified. Despite their comparative rarity, class I LysRSs conform to the canonical archaeal/bacterial division of the universal phylogenetic tree (13;14) . Strikingly, the class I (LysRS1) and class II (LysRS2) proteins are almost never found together, with organisms generally containing one or the other but not both. The only well documented example of the co-existence of LysRS1 and LysRS2 is in the Methanosarcinaceae, where they function together to aminoacylate the specialized tRNA Pyl suppressor species (15) .
Functional (16) and structural (17) characterizations have shown that LysRS1 and LysRS2 are functionally equivalent but structurally unrelated. Consequently, despite their lack of sequence similarity, the class I and II LysRSs are able to recognize the same amino acid and tRNA substrates both in vitro and in vivo, providing an example of functional convergence by divergent enzymes (12) . The two classes of LysRS proteins approach their RNA substrates from opposite sides, but recognize the same regions of tRNA Lys , namely the anticodon, acceptor stem and discriminator base (16) . Within these common recognition sites in tRNA Lys the relative importance of particular nucleotides varies for the two classes of LysRS (12) . These results show how the unrelated forms of LysRS perform the same cellular function, in this case tRNA Lys recognition, using different molecular mechanisms.
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Variation between LysRS1 and LysRS2 has also been observed for lysine activation.
LysRS2 initiates lysyl-tRNA synthesis using only lysine and ATP to generate an enzyme bound aminoacyl-adenylate, as do all class II and the majority of class I aaRSs, whereas the class I LysRS requires tRNA Lys binding prior to aminoacyl-adenylate synthesis, a feature shared by only a small sub-group of class I aaRSs (16;18-20) . Crystal structures of LysRS1 and LysRS2 complexed with L-lysine reveal that while their active site architectures are fundamentally different, the strategies for recognition of the R-group of L-lysine (but not the remainder of the molecule) are quite similar (17) . In order to compare the amino acid recognition strategies of LysRS1 and LysRS2 in more detail we have now studied the effects of L-lysine analogues on the aminoacylation reaction in vitro and in vivo. Significant differences in substrate recognition were found, providing both a rationale for the existence of two forms of LysRS and also suggesting a means of developing LysRS1 as a species-specific target for novel anti-infective agents.
Experimental Procedures
Bacterial strains and plasmids. Plasmid pKS-lysS (21) was used as the template for amplification of the E. coli lysS gene, with primers designed to generate a product flanked by NdeI and SapI sites. PCR was carried out using Platinum Pfx DNA polymerase (Stratagene) and the product cloned into TOPO-TA blunt end (Invitrogen). The gene was sequenced with two times coverage. Subsequently, the gene was excised and inserted into the pTYB1 vector to allow production of a LysRS2-intein fusion protein (IMPACT System, New England Biolabs).
Bacillus subtilis strain 168 (encoding B. subtilis LysRS2) and its derivative 157.1 (encoding Borrelia burgdorferi LysRS1, but not B. subtilis LysRS2) have previously been described (22) . Cells were routinely grown aerobically in LB media or in Spizizen's minimal media at 37° C (23). In vivo growth inhibition. Bacillus subtilis strains 168 and 157.1 were grown aerobically in LB media until OD600 = 1, 1 ml of this culture was then spun down and washed and resuspended in 1 ml Spizizen's minimal media. 250 µL of these cells were then inoculated in 25 mL of Spizizen's minimal media supplemented with 2 mM L-lysine or 5 µM of AEC or 400 mM L-γ-amino butyric acid at 37 o C.
Substrates

Results
Inhibition of LysRS1 and LysRS2 catalyzed in vitro aminoacylation -The aaRS catalyzed
aminoacylation of tRNA is a two-step reaction. In the first step, an amino acid is activated to form an enzyme-bound aminoacyl adenylate. The second step of the reaction involves binding of this complex by tRNA, whose 3'-end is then esterified with the aminoacyl-moiety followed by release of the resulting aminoacyl-tRNA. While LysRS1 and LysRS2 both utilize this overall reaction mechanism, they show a key difference at the first step; lysyl-adenylate synthesis by LysRS1 requires the presence of tRNA whereas LysRS2 can perform the reaction in the absence of tRNA. Given this difference between LysRS1 and LysRS2, we chose to compare their ability to recognize lysine and lysyl-adenylate analogues by determining the kinetics of inhibition of steady-state aminoacylation. This approach, rather than measurement of the inhibition of amino acid activation, would then allow more direct comparisons to be made between the two systems.
All compounds tested (Fig. 1) were found to act as competitive inhibitors of both LysRS1 and LysRS2, as judged by the observation of significant changes in KM but not kcat when comparing steady-state aminoacylation kinetic parameters with and without the addition of analogues ( Table 1) . The most potent inhibitor of both LysRS1 and LysRS2 was the lysyladenylate analogue lysylsulfamoyl-adenosine, which inhibited both enzymes equally well ( Table 1) . Analogues of L-lysine, rather than the adenylate derivative, were less potent inhibitors with Kis ranging from low µM (3.9 µM for AEC with LysRS2) to low mM (12 mM for D-lysine with LysRS2). The least effective inhibitors were the non-cognate amino acids, whose 
Growth inhibition by lysine analogues. -Comparison of the kinetics of inhibition of in vitro
aminoacylation by LysRS1 and LysRS2 indicated that several compounds preferentially inhibit one form of LysRS rather than the other. Lysine analogues with the strongest preferences were lysinamide and AEC, which showed 180 and 290 fold respectively lower Kis for LysRS2 than LysRS1, and γ-amino butyric acid, which had a 60 fold lower Ki for LysRS1 than LysRS2 (Table   1 ). To investigate whether these in vitro differences could be correlated with specific in vivo growth phenotypes, two related strains of B. subtilis were employed. 168 is a wild-type strain that employs LysRS2 for lysyl-tRNA synthesis, and 157.1 is a derivative of 168 where the endogenous LysRS2-encoding gene has been replaced by a gene encoding B. burgdorferi LysRS1 (22) . The growth of these strains in minimal media was monitored with and without the addition of varying concentrations of AEC, lysinamide and γ-amino butyric acid. Addition of lysinamide at concentrations up to 46 mM had no detectable effect on the growth rates of either strain 168 or 157.1 (data not shown). Growth in the presence of 5 µM AEC completely prevented growth of 168 but only resulted in an approximately 50% reduction in the growth rate of 157.1 (Fig. 2a) . Conversely, addition of 400 mM γ-amino butyric acid completely inhibited growth of 157.1 but only lowered the growth rate of 168 by about 50% (Fig. 2b) . These results are consistent with data from in vitro steady-state kinetics, confirming the selectivity of AEC and γ-amino butyric acid as preferential inhibitors of LysRS2 and LysRS1 respectively.
Aminoacylation with non-cognate amino acids using LysRS1 and LysRS2 -Previous studies of E. coli LysRS2 (lysS encoded) showed that the enzyme is able to activate and subsequently edit a number of non-cognate amino acids (33), and we have previously shown that AEC is a substrate for aminoacylation by LysRS1 (22) . We investigated the ability of LysRS1 and LysRS2 to aminoacylate tRNA Lys with a number of naturally occurring non-cognate amino acids shown above to be competitive inhibitors of the enzyme. Of the analogues tested L-lysine methyl ester, L-lysine ethyl ester, AEC and to a lesser extent L-ornithine were found to be substrates for aminoacylation of tRNA Lys by LysRS1 (Fig. 3b) . LysRS2 displayed a significantly broader substrate spectrum, catalyzing aminoacylation with D-lysine, L-lysine methyl ester, L-lysine ethyl ester, L-ornithine, AEC, L-lysine hydroxamate, L-α-amino butyric acid and to a lesser extent lysinamide, arginine and glutamate (Fig. 3a) .
Active site homology plots. The ability of certain compounds to selectively inhibit B. burgdorferi LysRS1 or E. coli LysRS2 in vitro and B. burgdorferi LysRS1 or B. subtilis LysRS2 in vivo suggests differences between the active site architectures of the two enzymes. In order to estimate the degree to which this divergent substrate discrimination might be conserved, sequence alignments were constructed from 44 LysRS1 and 137 representative LysRS2 predicted protein sequences using Clustal X (34). Conservation of amino acids (identity) was then scored for each position in the two LysRS alignments. This data was mapped onto the three dimensional structures of E. coli LysRS2 (lysS) (35) and P. horikoshii LysRS1 (17) (Figs. 4A and 4B). Examination of three-dimensional identity plots for both LysRS1 and LysRS2 showed a strikingly high degree of conservation throughout the lysine binding sites of both proteins (Figs. 4A and 4B ). This conservation of residues was seen in regions binding both the R-groups and the remainder of the lysine molecules, suggesting that the patterns of non-cognate amino acid discrimination observed above might be conserved in the LysRS1 and LysRS2 protein families.
Discussion
Comparison of amino acid discrimination by LysRS1 and LysRS2. The inhibition of aminoacylation by lysine analogues suggests several key similarities and differences between the two forms of LysRS. Both LysRSs showed a comparably strong enantiomeric selectivity for L-lysine over D-lysine, consistent with the general observation that L-amino acids are strongly favored throughout protein synthesis ( [36] and references therein). While LysRS2 was able to more easily aminoacylate tRNA Lys with D-lysine (Fig. 3a) , the level of D-lysine required was significantly higher than would be expected in vivo given estimates of microbial total lysine pools under normal growth conditions (37) . Similarly, the levels of arginine and ornithine required for inhibition of aminoacylation by both LysRS1 and LysRS2 are significantly higher than have been observed in vivo (38) indicating an adequate level of discrimination by both enzymes. Estimates of cellular concentrations of cadaverine are comparable to the Kis determined here, indicating specific protection exists against cadaverine inhibition at normal lysine levels as previously proposed (28) . While the Kis are significantly higher for L-glutamic acid than most of the other compounds tested, they are in fact not far removed from microbial glutamate concentrations, which may typically reach up to 80 mM or higher under certain growth conditions (e.g. [39] ). Taken together our data confirm that LysRS1 and LysRS2 are equally adept at discriminating against both the more common lysine analogs and the noncognate canonical amino acids. The ability to discriminate lysine from several of the analogues tested here was also recently described for the L box of B. subtilis, a lysine-responsive leader RNA that directly binds lysine, indicating that RNA and protein based systems offer equally effective mechanisms for specific recognition of lysine (40;41) .
Amongst the other amino acids tested all but one showed higher Kis for LysRS1 than for LysRS2, in agreement with the more compact binding pocket for the lysine backbone predicted from the structure of the class I enzyme (Fig. 4C) . L-lysine hydroxamate, L-lysine methyl ester, L-lysine ethyl ester and DL-5-hydroxylysine all show a marginal preference for inhibition of LysRS2 over LysRS1, with the Kis 2-6 fold higher for the class I enzyme, while L-α-amino butyric acid inhibits both enzymes to a similar degree. In contrast, AEC, L-lysinamide and L-γ-amino butyric acid were all found to be highly specific for a particular form of LysRS. AEC and lysinamide both show preferential inhibition of LysRS2 over LysRS1, with the Kis being 290 and 180 fold lower for the class II enzyme, respectively. The differences in AEC and lysinamide recognition reflect the more closed structure of LysRS1 around the amino acid backbone, where two conserved aromatic residues make hydrophobic interactions with the side chain as opposed to a single residue in LysRS2 (Figs. 4B and 4C ). The role of these residues is illustrated from modeling the binding of AEC at both active sites. In LysRS1, which binds AEC relatively poorly, there is some steric exclusion of the sulfur atom by His240 (Fig. 4C) . In contrast, the orientation of bound AEC and the absence of a second "packing" residue in LysRS2 allow inhibitor binding without a potential steric clash (Fig. 4D ), in agreement with the relatively strong binding of AEC. The importance of Trp218 and His240 in LysRS1 may be even more pronounced than is initially apparent from the existing tRNA-free structure. In a docking model of Pyrococcus horikoshii LysRS1 and tRNA (17), Trp218 and His240 (Trp 220 and His242 in B. burgdorferi) make stacking interactions with the terminal adenosine of tRNA suggesting that they may be more closely packed in the active site during aminoacylation. Such tRNA-mediated re-arrangements of active site residues have previously been observed in other class I aaRSs that, like LysRS1, require tRNA for amino acid activation (18-20;42) .
Of all the compounds compared as inhibitors of LysRS1 and LysRS2, only L-γ-amino butyric acid was a significantly better inhibitor of the class I enzyme. Examination of LysRS1 and LysRS2 active sites offers no obvious structural basis for this difference, although the relatively high Kis compared to most of the other analogues may be indicative of poor binding in both cases. While the kinetics of inhibition by L-γ-amino butyric acid suggest that neither form of LysRS binds this analogue well, in vivo data (discussed below) indicates that the difference in discrimination may be functionally significant.
LysRS1 displays a narrower substrate spectrum than LysRS2. The high degree of conservation of both LysRS1 and LysRS2 active site residues (Figs. 4A and 4B) suggests that their marked differences in sensitivity to numerous inhibitors may be of functional significance. This was strongly supported by aminoacylation data, which showed a far wider range of analogues could be stably attached to tRNA Lys by LysRS2 than by LysRS1. This difference could reflect the existence of a more proficient proofreading activity in LysRS1, or a more promiscuous active site in LysRS2. The possibility that proofreading prevents accumulation of mischarged tRNAs was not supported by our initial studies with LysRS1 (M.I. and H.R.
unpublished results) and would not be expected given that the closely related class 1b aaRSs glutaminyl-and glutamyl-tRNA synthetases have not been shown to catalyze such activities (reviewed in [4] ). Thus, the difference in substrate profiles between LysRS1 and LysRS2 can be attributed to a higher degree of substrate discrimination in the class I enzyme. This is in agreement with our recent study employing AEC, which suggested inefficient analogue recognition by LysRS1 could prevent miscoding of lysine codons during protein synthesis (22) .
The data presented here supports this finding and suggests that this function in translation might also extend to other analogues, given LysRS1's generally narrower substrate specificity.
One important exception is L-γ-amino butyric acid, whose ability to preferentially inhibit LysRS1 indicates LysRS2 can also function in translational quality control by excluding particular non-cognate amino acids. This was confirmed by the observation that production of where LysRS1 and LysRS2 apparently function together in suppressor tRNA charging (15) , and the other is Bacillus cereus where it is unclear if both LysRSs are produced (M.I. and K.Devine, unpublished data). In addition to providing a rationale for the existence and distribution of the two LysRSs, the divergence in substrate recognition confirms earlier proposals that LysRS1 may be a suitable target for the development of novel anti-microbials (43) . LysRS1 is found alone in a number of bacterial pathogens (e.g. B. burgdorferi, various Brucella and Rickettsia species, Treponema pallidum and Tropheryma whippelii ), and our findings indicate that it may be practical to target Lys-tRNA Lys synthesis in these organisms without disrupting the human host's LysRS2-mediated pathway. 
